Thermo Fisher Scientific Inc Total Assets
Thermo Fisher Scientific Inc total assets. Based on the latest financial reports, Thermo Fisher Scientific Inc (TMO) holds total assets worth $103.02 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Thermo Fisher Scientific Inc market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Thermo Fisher Scientific Inc (1985–2024)
Total assets of Thermo Fisher Scientific Inc from 1985 to 2024. This chart illustrates how Thermo Fisher Scientific Inc's total assets have evolved over time, based on quarterly financial data. See latest Thermo Fisher Scientific Inc stock price today for real-time trading data and today's change.
Thermo Fisher Scientific Inc - Asset Composition Analysis
Thermo Fisher Scientific Inc Total Assets Breakdown (December 2024)
Thermo Fisher Scientific Inc total assets breakdown as of December 2024. Thermo Fisher Scientific Inc's total assets of $103.02 Billion consist of 22.8% current assets and 77.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $4.01 Billion | 4.1% |
| Accounts Receivable | $9.63 Billion | 9.9% |
| Inventory | $4.98 Billion | 5.1% |
| Property, Plant & Equipment | $10.79 Billion | 11.1% |
| Intangible Assets | $15.53 Billion | 16.0% |
| Goodwill | $45.85 Billion | 47.1% |
Asset Composition Trend (1985–2024)
This chart illustrates how Thermo Fisher Scientific Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Thermo Fisher Scientific Inc to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Thermo Fisher Scientific Inc's current assets represent 22.8% of total assets in 2024, a decrease from 59.3% in 1985.
- Cash Position: Cash and equivalents constituted 4.1% of total assets in 2024, down from 13.5% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 13.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 47.1% of total assets.
Thermo Fisher Scientific Inc Competitors by Total Assets
Key competitors of Thermo Fisher Scientific Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.00 Billion |
|
Diagnósticos da América S.A
SA:DASA3
|
Brazil | R$21.10 Billion |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.52 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$512.35 Million |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.66 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
Thermo Fisher Scientific Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.50 | 1.63 | 2.13 |
| Quick Ratio | 1.11 | 1.26 | 1.74 |
| Cash Ratio | 0.00 | 0.32 | 0.00 |
| Working Capital | $7.41 Billion | $9.18 Billion | $11.65 Billion |
Thermo Fisher Scientific Inc - Advanced Valuation Insights
This section examines the relationship between Thermo Fisher Scientific Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.32 |
| Latest Market Cap to Assets Ratio | 2.31 |
| Asset Growth Rate (YoY) | -1.4% |
| Total Assets | $97.32 Billion |
| Market Capitalization | $224.59 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Thermo Fisher Scientific Inc's assets at a significant premium (2.31x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Thermo Fisher Scientific Inc's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Thermo Fisher Scientific Inc (1985–2024)
The table below shows the annual total assets of Thermo Fisher Scientific Inc from 1985 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $97.32 Billion | -1.42% |
| 2023-12-31 | $98.73 Billion | +1.62% |
| 2022-12-31 | $97.15 Billion | +2.14% |
| 2021-12-31 | $95.12 Billion | +37.76% |
| 2020-12-31 | $69.05 Billion | +18.28% |
| 2019-12-31 | $58.38 Billion | +3.82% |
| 2018-12-31 | $56.23 Billion | -0.77% |
| 2017-12-31 | $56.67 Billion | +23.44% |
| 2016-12-31 | $45.91 Billion | +12.43% |
| 2015-12-31 | $40.83 Billion | -4.71% |
| 2014-12-31 | $42.85 Billion | +34.49% |
| 2013-12-31 | $31.86 Billion | +16.10% |
| 2012-12-31 | $27.44 Billion | +2.28% |
| 2011-12-31 | $26.83 Billion | +25.47% |
| 2010-12-31 | $21.39 Billion | -0.99% |
| 2009-12-31 | $21.60 Billion | +2.42% |
| 2008-12-31 | $21.09 Billion | -0.55% |
| 2007-12-31 | $21.21 Billion | -0.26% |
| 2006-12-31 | $21.26 Billion | +400.10% |
| 2005-12-31 | $4.25 Billion | +18.87% |
| 2004-12-31 | $3.58 Billion | +5.54% |
| 2003-12-31 | $3.39 Billion | -7.08% |
| 2002-12-31 | $3.65 Billion | -4.65% |
| 2001-12-31 | $3.83 Billion | -21.34% |
| 2000-12-31 | $4.86 Billion | -6.15% |
| 1999-12-31 | $5.18 Billion | -18.16% |
| 1998-12-31 | $6.33 Billion | +9.24% |
| 1997-12-31 | $5.80 Billion | +12.73% |
| 1996-12-31 | $5.14 Billion | +37.29% |
| 1995-12-31 | $3.74 Billion | +24.01% |
| 1994-12-31 | $3.02 Billion | +22.08% |
| 1993-12-31 | $2.47 Billion | +36.04% |
| 1992-12-31 | $1.82 Billion | +51.59% |
| 1991-12-31 | $1.20 Billion | +33.54% |
| 1990-12-31 | $898.20 Million | +44.03% |
| 1989-12-31 | $623.60 Million | +27.24% |
| 1988-12-31 | $490.10 Million | +15.02% |
| 1987-12-31 | $426.10 Million | +37.94% |
| 1986-12-31 | $308.90 Million | +39.33% |
| 1985-12-31 | $221.70 Million | -- |
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines,… Read more